Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeName |
gptkb:ETV:IDS
|
| gptkbp:clinicalTrialPhase |
Phase 1/2
|
| gptkbp:crosses |
gptkb:blood-brain_barrier
|
| gptkbp:developedBy |
gptkb:Denali_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
DNL310
|
| gptkbp:intendedUse |
gptkb:Hunter_syndrome
|
| gptkbp:mechanismOfAction |
enzyme replacement therapy
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:iduronate-2-sulfatase
|
| gptkbp:bfsParent |
gptkb:Denali_Therapeutics
|
| gptkbp:bfsLayer |
7
|